Pantoprazole Mepha

Pantoprazole, the active ingredient in Pantoprazole Mepha, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is indicated for conditions such as gastro‑esophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and prevention of NSAID‑induced gastric ulcers.

GNH USA supplies Pantoprazole Mepha as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing therapeutic benefit in several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Erosive esophagitis: facilitates mucosal healing and prevents disease progression. - Zollinger‑Ellison syndrome: controls excessive gastric acid production. - Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients requiring non‑steroidal anti‑inflammatory drugs.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea, abdominal cramping. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome: skin blistering and detachment. - Interstitial nephritis: kidney inflammation, reduced urine output.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in patients with severe impairment. - Monitor magnesium levels: long‑term treatment may cause hypomagnesemia. - Review concomitant medications: avoid known contraindicated drugs such as atazanavir. - Use caution in hepatic impairment: dose may need adjustment. - Store at ambient temperature: keep in the original pack, protect from moisture.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of atazanavir. - High‑dose methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: elevated serum concentrations. - Diazepam: enhanced sedative effect.